LNTH Stock Jump 22% After Beating Fourth Quarter Earnings Expectations

LNTH Stock a company committed to improving patient outcomes through diagnostics, radiotherapeutics, and artificial intelligence solutions, has reported strong financial results for the fourth quarter and full year of 2022. LNTH stock revenue increased significantly, and it has also provided positive guidance for the first quarter and full year of 2023.LNTH stock is traded on NASDAQ and is currently trading at $71.00 with a +12.75 (+21.89%) gain in Pre-Market 9:00 AM EST. The company’s 50-Day Moving Average Price is $54.43 and its 200-Day Moving Average Price is $65.7. LNTH stock Market Capitalization is 4.01 billion, and its Shares Outstanding are 68.83 million.

LNTH stock Impressive revenue growth

Lantheus Holdings, Inc (LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, has reported its fourth quarter and full year 2022 financial results. The company has seen a significant increase in worldwide revenue of $263.2 million and $935.1 million for the fourth quarter and full year 2022, representing increases of 103.1% and 119.9% over the prior year periods, respectively.

LNTH stock Net loss & Net income

The company’s fourth quarter 2022 GAAP net loss was $119.2 million, or $1.74 per fully diluted share, as compared to GAAP net loss of $40.2 million, or $0.59 per fully diluted share for the fourth quarter of 2021. Full year 2022 GAAP net income was $28.1 million, or $0.40 per fully diluted share, as compared to GAAP net loss of $71.3 million, or $1.06 per fully diluted share for the full year 2021.

The Company’s fourth quarter 2022 adjusted fully diluted net income per share, or earnings per share (“EPS”), were $1.37, as compared to $0.25 for the fourth quarter of 2021, representing an increase of approximately $1.12 from the prior year period. The Company’s full year 2022 adjusted fully diluted EPS, were $4.22, as compared to $0.49 for the full year 2021, representing an increase of approximately $3.72 from the prior year period.

The net cash provided by operating activities was $105.4 million and $281.8 million for the fourth quarter and full year 2022. Free Cash Flow was $100.6 million for the fourth quarter of 2022, as compared to $9.3 million for the fourth quarter of 2021, representing an increase of approximately $91.3 million from the prior year period. Full year 2022 free cash flow was $263.4 million, as compared to $41.8 million for the full year 2021, representing an increase of approximately $221.7 million from the prior year period.

Guidance For First Quarter And Full Year 2023

The company provides first quarter and full year 2023 revenue and adjusted diluted earnings per share guidance. According to the guidance issued on February 23, 2023, the company’s first quarter of 2023 revenue is estimated to be between $280 million – $285 million, and adjusted fully diluted EPS is estimated to be between $1.28 – $1.32. For the full year 2023, the company’s revenue is estimated to be between $1.140 billion – $1.160 billion, and adjusted fully diluted EPS is estimated to be between $4.95 – $5.10.

Lantheus Holdings, Inc (LNTH) has seen an impressive 101.84% 1-year price change and a 261.58% 3-years price change. It has also been estimated that the company’s average EPS will be 1.16, the estimated EPS High will be 1.39, and the estimated EPS Low will be 0.92.

In addition, the company’s cash position improved in the fourth quarter, as net cash provided by operating activities increased to $105.4 million, up from $9.3 million in the fourth quarter of 2021. Free cash flow, a measure of cash generated from operations after capital expenditures, was $100.6 million for the fourth quarter of 2022, compared to $9.3 million for the same period last year, representing an increase of approximately $91.3 million from the prior year period. The company also saw a strong increase in adjusted fully diluted EPS for the fourth quarter of 2022, with earnings per share of $1.37, up from $0.25 for the fourth quarter of 2021.

Positive Analyst Estimates For Future Revenue And Earnings

Investors will likely be keeping a close eye on the stock in the coming months, as the company has issued guidance for the first quarter and full year of 2023. According to Lantheus Holdings, it expects revenue in the first quarter of 2023 to be in the range of $280 million to $285 million, with adjusted fully diluted EPS expected to be between $1.28 and $1.32. For the full year 2023, the company has provided guidance for revenue of $1.140 billion to $1.160 billion, and adjusted fully diluted EPS of $4.95 to $5.10.

Lantheus Holdings is a company committed to improving patient outcomes through diagnostics, radiotherapeutics, and artificial intelligence solutions that enable clinicians to find, fight, and follow disease. The company’s portfolio includes a range of medical imaging agents, as well as the innovative cancer treatment product Lutathera, which has received regulatory approval in the United States and Europe.

Conclusion

In summary, Lantheus Holdings’ strong financial results for the fourth quarter and full year of 2022 have driven a surge in its stock price. LNTH stock’s revenue increased by 103.1% and 119.9% for the fourth quarter and full year of 2022, respectively, compared to the prior year periods. The company’s net cash provided by operating activities was $105.4 million and $281.8 million for the fourth quarter and full year of 2022, respectively. The company has also issued guidance for the first quarter and full year of 2023, which suggests that it expects to maintain its growth trajectory. Investors will likely be watching LNTH stock’s progress closely in the coming months.

Join the conversation

or to participate.